FDA approves new indication for Gilotrif
from Pharmacy Practice News
The FDA granted a new indication for oral afatinib for the first-line treatment of patients with metastatic non-small cell lung cancer, whose tumors have nonresistant epidermal growth factor receptor gene mutations.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063